- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2021-006041-36.
Displaying page 1 of 1.
EudraCT Number: 2021-006041-36 | Sponsor Protocol Number: PH-L19IL2TNFBASK-04/21 | Start Date*: 2022-02-08 |
Sponsor Name:Philogen S.p.A. | ||
Full Title: A phase II study of L19IL2/L19TNF in patients with skin cancers amenable to intralesional treatment | ||
Medical condition: Patients with malignant tumors of the skin amenable to intratumoral injection, and in a curative or neoadjuvant or palliative intention, including: • Basal cell carcinoma (BCC) • Cutaneous squamou... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) IT (Trial now transitioned) ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
